Skip to main content
. 2011 Apr 30;32(Suppl 1):99–104. doi: 10.1007/s10072-011-0547-y

Table 1.

Results for the comparison of study endpoints between the two treatment groups

Frovatriptan Zolmitriptan p
Pain-relief episodes at 2 h 31 (52) 26 (53) NS
Pain-free episodes at 2 h 16 (22) 17 (26) NS
Pain-relief episodes at 24 h 50 (83) 40 (82) NS
Pain-free episodes at 24 h 54 (74) 45 (69) NS
Recurrent episodes at 24 h 11 (15) 14 (22) <0.05

Data are reported as absolute (n) and relative (%) frequency. P refers to the statistical significance of the difference between the two study drugs